# Tenecteplase Compared to Alteplase for Patients With Large Vesel Oclusion Suspicion Before Thrombectomy

> **NCT05626972** · PHASE3 · UNKNOWN · sponsor: **Hospital Universitari Vall d'Hebron Research Institute** · enrollment: 500 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** Tenecteplase

## Key facts

- **NCT ID:** NCT05626972
- **Lead sponsor:** Hospital Universitari Vall d'Hebron Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-27
- **Primary completion:** 2023-05
- **Final completion:** 2024-05
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2022-11-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05626972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05626972, "Tenecteplase Compared to Alteplase for Patients With Large Vesel Oclusion Suspicion Before Thrombectomy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05626972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*